Sohini Das And Shine Jacob

Stories by Sohini Das And Shine Jacob

Covaxin: How Bharat Biotech plans to boost immunity

Covaxin: How Bharat Biotech plans to boost immunity

Rediff.com   6 Oct 2020

Adjuvants may be added to a vaccine to produce more antibodies and longer lasting immunity thus minimising the dose of antigen needed.

Sales of Biocon's itolizumab surge as phase-4 clinical trials begin

Sales of Biocon's itolizumab surge as phase-4 clinical trials begin

Rediff.com   6 Oct 2020

In India, itolizumab, known by the brand name Alzumab, has been priced at Rs 8,000 per vial. Most patients require four vials for Covid-19 treatment, taking the cost of the therapy to Rs 32,000.

Covid vaccine: Pharma firms ready expansion plans

Covid vaccine: Pharma firms ready expansion plans

Rediff.com   6 Oct 2020

The Indian vaccine industry largely feels there are two ways in which vaccine innovation can be spurred - one, get a high price for the product and two, have the government buy a few hundred million doses of the product at a certain price.

Newbies dream to become oil barons in limbo

Newbies dream to become oil barons in limbo

Rediff.com   3 Oct 2020

22 companies won bids for the 31 contracts on offer; 15 were new entrants to the oil and gas business. Three years on, none of them have started production.

Indian Railways back on track, stems fall in freight traffic

Indian Railways back on track, stems fall in freight traffic

Rediff.com   2 Oct 2020

Revenue from freight operations also increased by 14 per cent to Rs 9,903 crore in September.

Bharat Petroleum likely to sell 7.3% treasury stock in bulk deal

Bharat Petroleum likely to sell 7.3% treasury stock in bulk deal

Rediff.com   29 Sep 2020

Going by the current market cap of Rs 83,451.15 crore, 7.33 per cent stake in BPCL is expected to be valued around Rs 6,117 crore.

L&T, 2 mega consortia in race for India's first bullet train project

L&T, 2 mega consortia in race for India's first bullet train project

Rediff.com   24 Sep 2020

The first consortium includes Afcons Infrastructure, IRCON International and JMC Projects, while the second group of companies include NCC, Tata Projects and J. Kumar Infra Projects.

Adani, GMR among 20 firms keen on rebuilding New Delhi railway station

Adani, GMR among 20 firms keen on rebuilding New Delhi railway station

Rediff.com   23 Sep 2020

The Rail Land Development Authority has invited online bids from private players to redevelop the station into an integrated commercial, retail, and hospitality hub.

Threat of demolition still hounds 300,000 Delhi slum-dwellers

Threat of demolition still hounds 300,000 Delhi slum-dwellers

Rediff.com   19 Sep 2020

'The people, media and politicians are ready to listen to the troubles of Kangana Ranaut, but we are unwanted lives in the heart of Delhi.' Shine Jacob reports.

How India is gearing up to distribute Covid-19 vaccine

How India is gearing up to distribute Covid-19 vaccine

Rediff.com   18 Sep 2020

A model being considered is to have a combined cold chain approach - where the agricultural cold chain would be combined with vaccine cold chains.

Railways to allow private players for bullet train projects

Railways to allow private players for bullet train projects

Rediff.com   18 Sep 2020

The projects - Delhi-Varanasi, Mumbai-Nagpur, Delhi-Ahmedabad, Chennai-Mysore, Delhi-Amritsar, Mumbai-Hyderabad, and Varanasi-Howrah - are expected to cost around Rs 10 trillion.

Prayagraj to house Indian Railways' ambitious freight programme

Prayagraj to house Indian Railways' ambitious freight programme

Rediff.com   15 Sep 2020

Built by the French railway technology company Alstom, it will host a 90-metre-long digital wall for train operation, said to be the second largest in Asia.

Labs bet on Covid tests for next growth phase

Labs bet on Covid tests for next growth phase

Rediff.com   14 Sep 2020

The bouquet of Covid-19 tests that most diagnostic labs are offering include antibody tests (blood tests), rapid antigen tests (point of care tests that detect the presence of an antigen from a nasal or throat swab in case of SARS-CoV-2), and reverse transcription-polymerase chain reaction (RT-PCR) tests.

India will wait for DCGI nod to restart Oxford vaccine trial

India will wait for DCGI nod to restart Oxford vaccine trial

Rediff.com   11 Sep 2020

The global trials were halted after a study participant suffered a 'potentially unexplained illness, reports Sohini Das.

BPCL privatisation move make workers jittery

BPCL privatisation move make workers jittery

Rediff.com   8 Sep 2020

Older workers are headed for the VRS exit in larger-than-expected numbers even as unrest stirs over unrevised wage settlements.

With coronavirus still around, 'virus killers' hit the market

With coronavirus still around, 'virus killers' hit the market

Rediff.com   7 Sep 2020

A gamechanger for offices and factories, Shycocan, claims to be able to clear an area of 1000 square feet from coronavirus.

Railway Board restructuring gets green flag

Railway Board restructuring gets green flag

Rediff.com   4 Sep 2020

The board will now be headed by Vinod Kumar Yadav as chairman and CEO, and it will have four other members.

In the works: Priority list of who will get Covid vaccine first

In the works: Priority list of who will get Covid vaccine first

Rediff.com   4 Sep 2020

The Centre has also contacted five domestic and three multinational vaccine makers to understand how soon a candidate vaccine against Covid-19 will be ready.

Indian pharma firms working on new repurposed drug for Covid-19

Indian pharma firms working on new repurposed drug for Covid-19

Rediff.com   2 Sep 2020

Many companies globally are working on plasma research to develop and manufacture hyperimmune globulin therapies from plasma donations.

Pandemic brings windfall for e-pharma companies

Pandemic brings windfall for e-pharma companies

Rediff.com   27 Aug 2020

The online pharmacy market, which was worth about $512 million in 2018, is growing at a CAGR of 63 per cent and is expected to hit overall revenues of over $3.6 billion by 2022.